For research use only. Not for therapeutic Use.
LGD-2226(CAT: R036606) is a derivative of quinolinone. As an oral selective androgen receptor agonist, LGD-2226 has anabolic effects in both muscle and bone tissue and is currently used to treat diseases such as muscle atrophy and osteoporosis. This product is used in organic synthesis, pharmaceutical research and development, and other scientific research fields.
Catalog Number | R036606 |
CAS Number | 328947-93-9 |
Synonyms | 6-[Bis(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-2(1H)-quinolinone; |
Molecular Formula | C14H9F9N2O |
Purity | ≥95% |
Target | androgen receptor modulator |
Storage | -20°C |
IUPAC Name | 6-[bis(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-1H-quinolin-2-one |
InChI | InChI=1S/C14H9F9N2O/c15-12(16,17)5-25(6-13(18,19)20)7-1-2-10-8(3-7)9(14(21,22)23)4-11(26)24-10/h1-4H,5-6H2,(H,24,26) |
InChIKey | ULBPQWIGZUGPHU-UHFFFAOYSA-N |
SMILES | C1=CC2=C(C=C1N(CC(F)(F)F)CC(F)(F)F)C(=CC(=O)N2)C(F)(F)F |
Reference | <br /> |